TacticScaleWhat Topchoice Medical (通策医疗) Does & How It Makes Money (600763.SS)
Updated October 2026 · reflects Topchoice Medical's latest reported financials
Chinese dental care provider operating oral medical services. The company mainly earns revenue from fees for dental and oral medical services provided to patients.
How Topchoice Medical makes money
The company mainly earns revenue from fees for dental and oral medical services provided to patients. It adds income from selling medical equipment and disinfection products, plus training, technology services and investment management.
What Topchoice Medical does
Topchoice Medical Co., Inc. is a Hangzhou-based healthcare company focused on oral and dental medical services in China. Incorporated in 1995, it was previously named Topchoice Medical Investment Co., Inc. and took its current name in November 2019, reflecting its shift toward running medical services directly. Dental care is the core of the business. The company also sells medical equipment, disinfection products and daily necessities, and runs import/export, investment management, technology development and consulting, and training activities that support its dental operations.
Products & services
- Dental medical services
- Oral healthcare services
- Medical equipment sales
- Disinfection products
- Training services
- Technology consulting and services
通策医疗是做什么的？
通策医疗（Topchoice Medical Co., Inc.）成立于1995年，总部位于浙江杭州，主要在中国提供口腔（牙科）医疗服务。公司原名通策医疗投资股份有限公司，2019年11月更名为现名，更加突出医疗服务主业。 除口腔诊疗这一核心业务外，公司还从事医疗器械、消毒用品及日用品的销售，以及进出口、投资管理、技术开发与咨询和培训服务，为口腔医疗主业提供配套。
What is Topchoice Medical worth?
On an owner-earnings DCF, Topchoice Medical's most-likely value is about ¥17 versus a recent price near ¥34 (96% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~¥8) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Zhende Medical (603301.SS) · Henry Schein (HSIC) · Double Medical Technology (002901.SZ)